SS INNOVATIONS INTERNATIONAL, INC. (SSII) Operating Margin
- Operating margin · 12 months: Value (m); Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | (m) | Operating income / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | -8.47M USD | Operating Income (Loss) |
| Revenue | (m) | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) | |
| Research and development | 5.57M USD | Research and Development Expense |
| Selling, general and administration | 17.15M USD | Selling, General and Administrative Expense |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $-8.47M | (m) | (m) | $5.57M | $17.15M | (m) |
| 2026-03-31 | $-5.91M | $48.47M | (m) | $3.67M | $15.94M | -12.20% |
| 2025-12-31 | $-8.19M | $42.48M | (m) | $3.69M | $14.85M | -19.29% |
| 2025-09-30 | $-9.30M | $36.07M | (m) | $3.06M | $14.02M | -25.78% |
| 2025-06-30 | $-10.67M | $27.62M | (m) | $2.71M | $11.71M | -38.62% |
| 2025-03-31 | $-15.07M | $22.13M | (m) | $2.97M | $10.72M | -68.07% |
| 2024-12-31 | $-18.98M | $20.65M | (m) | $2.49M | $10.16M | -91.90% |
| 2024-09-30 | $-28.58M | (m) | (m) | $1.52M | $9.29M | (m) |
| 2024-06-30 | $-23.41M | (m) | (m) | (m) | $10.87M | (m) |
| 2024-03-31 | $-20.42M | (m) | (m) | $970.26K | $6.29M | (m) |
| 2023-12-31 | $-20.67M | (m) | (m) | $576.17K | $5.16M | (m) |
| 2023-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | $-5.68M | (m) | (m) | $83.28K | $3.25M | (m) |
| 2022-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| CARLSMED, INC. (CARL) | United States | $0.405B |